Shrestha Ruchi, Singh Prerana, Dhakhwa Parami, Tetali Shailaja, Batchu Tripura, Shrestha Thapa Pragati
Department of Vitreoretina, Reiyukai Eiko Masunaga Eye Hospital, Banepa, Nepal.
SEVA Nepal, Kathmandu, Nepal.
JMIR Res Protoc. 2021 Dec 17;10(12):e33116. doi: 10.2196/33116.
Diabetic retinopathy (DR) is an important public health issue in Nepal with a huge social and economic impact. Despite the availability of retinal services, people may not access them because of the lack of knowledge about DR and poor referral systems. Published studies on referral pathways in Nepal are scarce. Improving DR awareness among general physicians has the potential to address these challenges.
The aim of this study is to evaluate the effect of a health education intervention on health personnel, establish a referral pathway, and assess the impact of the intervention on the attendance of patients with diabetes mellitus for retinal screening at Reiyukai Eiko Masunaga Eye Hospital in Nepal.
This is a nonrandomized, pre- and postintervention study. Health education on DR will be provided to selected health personnel of the intervention hospital (Scheer Memorial) using information education and communication (IEC) materials in the form of PowerPoint presentations, posters, pamphlets, videos, and pre- and postevaluation questionnaires along with referral slip. Pre- and postevaluation will be undertaken during the study period. Data will be analyzed using MS Excel and Epi Info 7.
The ethical approval for this study has been obtained from the Ethical Review Board of the Nepal Health Research Council (ERB Protocol Registration Number # 582/2020P). The study is expected to be completed in 18 months from the start of the project. The baseline data collection was from June to January 2020 for a period of 8 months. The postintervention data collection was from February to September 2021 for a period of 8 months. The last 2 months are planned for data analysis and report writing.
Health education intervention could be a low-cost solution to improve the awareness, access, and utilization of retinal health care services; this is an understudied topic in Nepal. Working closely with the stakeholders, this study will evaluate the role of health education interventions (which are already validated in other low-income settings) to strengthen referral and reduce the burden of DR in Nepal.
ClinicalTrials.gov NCT04829084; https://clinicaltrials.gov/ct2/show/NCT04829084.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/33116.
糖尿病视网膜病变(DR)是尼泊尔一个重要的公共卫生问题,具有巨大的社会和经济影响。尽管有视网膜服务,但由于人们对DR缺乏了解且转诊系统不完善,他们可能无法获得这些服务。尼泊尔关于转诊途径的已发表研究很少。提高普通内科医生对DR的认识有可能应对这些挑战。
本研究的目的是评估健康教育干预对卫生人员的效果,建立转诊途径,并评估该干预对尼泊尔灵友会荣光学园增永眼科医院糖尿病患者视网膜筛查就诊率的影响。
这是一项非随机的干预前后研究。将使用PowerPoint演示文稿、海报、宣传册、视频等形式的信息教育与沟通(IEC)材料以及转诊单,对干预医院(舍尔纪念医院)选定的卫生人员进行DR健康教育,并进行预评估和后评估问卷。在研究期间进行预评估和后评估。数据将使用MS Excel和Epi Info 7进行分析。
本研究已获得尼泊尔卫生研究理事会伦理审查委员会的伦理批准(ERB协议注册号#582/2020P)。预计该研究将从项目开始起18个月内完成。基线数据收集时间为2020年6月至1月,为期8个月。干预后数据收集时间为2021年2月至9月,为期8个月。计划最后2个月进行数据分析和报告撰写。
健康教育干预可能是提高视网膜保健服务的认识、可及性和利用率的低成本解决方案;这在尼泊尔是一个研究不足的课题。本研究将与利益相关者密切合作,评估健康教育干预(已在其他低收入环境中得到验证)在加强转诊和减轻尼泊尔DR负担方面的作用。
ClinicalTrials.gov NCT04829084;https://clinicaltrials.gov/ct2/show/NCT04829084。
国际注册报告识别号(IRRID):DERR1-10.2196/33116。